Cargando…
Nanoparticles as an effective drug delivery system in COVID-19
BACKGROUND: The global healthcare sector has been dealing with a situation known as a novel severe acute respiratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is an acronym for Covid-19 (Coronavirus Disease- 2019). It causes a respiratory infection that includes cold, sneezing and coughi...
Autores principales: | Chowdhury, Neehasri Kumar, Deepika, Choudhury, Reshma, Sonawane, Gaurav Ambadas, Mavinamar, Shankar, Lyu, Xiaoming, Pandey, Ramendra Pati, Chang, Chung-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426213/ https://www.ncbi.nlm.nih.gov/pubmed/34649334 http://dx.doi.org/10.1016/j.biopha.2021.112162 |
Ejemplares similares
-
Experimental Methods for the Biological Evaluation of Nanoparticle-Based Drug Delivery Risks
por: Pandey, Ramendra Pati, et al.
Publicado: (2023) -
Emerging Concern with Imminent Therapeutic Strategies for Treating Resistance in Biofilm
por: Pandey, Ramendra Pati, et al.
Publicado: (2022) -
Antimicrobial resistance surveillance system mapping in different countries
por: Pandey, Ramendra Pati, et al.
Publicado: (2022) -
Silver Nanoparticles Phytofabricated through Azadirachta indica: Anticancer, Apoptotic, and Wound-Healing Properties
por: Dutt, Yogesh, et al.
Publicado: (2023) -
A Systematic Review on the Emergence of Omicron Variant and Recent Advancement in Therapies
por: Konyak, Beyau M., et al.
Publicado: (2022)